Clinical Trials
23 trialsNCT05735717 2026-04-06
MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
Masonic Cancer Center, University of Minnesota
Phase 2 Recruiting
NCT07485855 2026-03-24
(HEM-FLU)
Asan Medical Center
Phase 3 Recruiting
NCT06229392 2026-03-11
A Study to Evaluate the Intratumoral Influenza Vaccine Administration in Patients With Breast Cancer
Rush University Medical Center
Phase 1 Withdrawn
NCT04712539 2026-02-11
Baloxavir and Oseltamivir for the Treatment of Severe Influenza Infection in Immunocompromised Patients
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT03396575 2025-10-29
BRAVO
University of Florida
Phase 1 Terminated
NCT03955991 2025-06-26
VSMART
University of Miami
Phase 4 Completed
NCT06124131 2025-05-04
BENEFIT-C
Tulane University
Phase NA Completed
NCT02860039 2024-10-22
High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant
Vanderbilt-Ingram Cancer Center
Phase 2 Completed
NCT05116917 2024-05-28
INFLUENCE
Herlev Hospital
Phase 2 Terminated
NCT02108366 2019-10-21
Treatment of Severe Influenza A Infection
The University of Hong Kong
Phase 3 Completed
NCT03590808 2019-09-19
Influenza Vaccination in Patients Receiving Immune Checkpoint Inhibitor
Seoul National University Hospital
Phase NA Completed
NCT02566265 2019-01-30
SHIVERING 2
Yale University
Phase 2 Completed
NCT01924169 2018-09-20
Lenalidomide as Immune Adjuvant in Patient's With Chronic Lymphocytic Leukemia (CLL)
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT01215981 2017-12-28
Influenza Vaccine Post Allogeneic Transplant
Masonic Cancer Center, University of Minnesota
Phase NA Terminated
NCT01205581 2016-09-23
Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV
St. Jude Children's Research Hospital
Phase 2 Completed
NCT01666782 2016-06-24
IMMUNE
Rochester General Hospital
Phase 2 Completed
NCT02213432 2016-02-24
Influenza Vaccination in Cancer Patients
Seoul National University Hospital
Phase NA Terminated
NCT01707628 2014-01-31
Rituxivac
St. Antonius Hospital
Phase NA Completed
NCT01698177 2013-04-19
Optimizing Influenza Vaccination in Surgical Oncology Patients
Stony Brook University
Phase 4 Unknown
NCT00962715 2012-08-03
Reactogenicity, Immunogenicity of Trivalent Influenza Vaccine With Recombinant Interferon Alpha Among Chronic Lymphocytic Leukemia
M.D. Anderson Cancer Center
Phase 1/2 Withdrawn
NCT00307710 2012-07-31
Influenza Vaccination in Patients Receiving Antineoplastic Therapy for Non-Hodgkin's Lymphoma
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00906750 2011-10-13
FMRESP
St. Jude Children's Research Hospital
Phase 1 Completed
NCT01016548 2010-06-04
Evaluation of Influenza H1N1 Vaccine in Adults With Lymphoid Malignancies on Chemotherapy
University Health Network, Toronto
Phase 3 Completed